vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and ESAB Corp (ESAB). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $727.8M, roughly 1.3× ESAB Corp). APTARGROUP, INC. runs the higher net margin — 7.7% vs 7.5%, a 0.2% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 8.5%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $70.3M). Over the past eight quarters, ESAB Corp's revenue compounded faster (2.8% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
ESAB, Elektriska Svetsnings-Aktiebolaget, is an American-Swedish industrial company.
ATR vs ESAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $727.8M |
| Net Profit | $74.3M | $54.8M |
| Gross Margin | — | 37.0% |
| Operating Margin | 11.0% | 14.6% |
| Net Margin | 7.7% | 7.5% |
| Revenue YoY | 13.5% | 8.5% |
| Net Profit YoY | -26.4% | 2.1% |
| EPS (diluted) | $1.13 | $0.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $727.8M | ||
| Q3 25 | $961.1M | $715.6M | ||
| Q2 25 | $966.0M | $678.1M | ||
| Q1 25 | $887.3M | — | ||
| Q4 24 | $848.1M | $670.8M | ||
| Q3 24 | $909.3M | $673.3M | ||
| Q2 24 | $910.1M | $707.1M | ||
| Q1 24 | $915.4M | $689.7M |
| Q4 25 | $74.3M | $54.8M | ||
| Q3 25 | $127.9M | $66.9M | ||
| Q2 25 | $111.7M | $67.4M | ||
| Q1 25 | $78.8M | — | ||
| Q4 24 | $100.9M | $53.7M | ||
| Q3 24 | $100.0M | $68.2M | ||
| Q2 24 | $90.5M | $82.9M | ||
| Q1 24 | $83.1M | $60.0M |
| Q4 25 | — | 37.0% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | — | 37.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 37.7% | ||
| Q2 24 | — | 38.2% | ||
| Q1 24 | — | 37.0% |
| Q4 25 | 11.0% | 14.6% | ||
| Q3 25 | 14.2% | 15.2% | ||
| Q2 25 | 14.9% | 16.2% | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 14.2% | 16.6% | ||
| Q3 24 | 15.2% | 15.7% | ||
| Q2 24 | 13.8% | 16.9% | ||
| Q1 24 | 12.2% | 16.0% |
| Q4 25 | 7.7% | 7.5% | ||
| Q3 25 | 13.3% | 9.3% | ||
| Q2 25 | 11.6% | 9.9% | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 11.9% | 8.0% | ||
| Q3 24 | 11.0% | 10.1% | ||
| Q2 24 | 9.9% | 11.7% | ||
| Q1 24 | 9.1% | 8.7% |
| Q4 25 | $1.13 | $0.90 | ||
| Q3 25 | $1.92 | $1.09 | ||
| Q2 25 | $1.67 | $1.10 | ||
| Q1 25 | $1.17 | — | ||
| Q4 24 | $1.48 | $0.87 | ||
| Q3 24 | $1.48 | $1.11 | ||
| Q2 24 | $1.34 | $1.35 | ||
| Q1 24 | $1.23 | $0.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $218.2M |
| Total DebtLower is stronger | $1.1B | $1.3B |
| Stockholders' EquityBook value | $2.7B | $2.1B |
| Total Assets | $5.3B | $4.9B |
| Debt / EquityLower = less leverage | 0.43× | 0.63× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $218.2M | ||
| Q3 25 | $264.8M | $258.2M | ||
| Q2 25 | $169.8M | $291.3M | ||
| Q1 25 | $136.8M | — | ||
| Q4 24 | $226.2M | $249.4M | ||
| Q3 24 | $327.9M | $253.7M | ||
| Q2 24 | $223.9M | $228.5M | ||
| Q1 24 | $201.1M | $76.5M |
| Q4 25 | $1.1B | $1.3B | ||
| Q3 25 | $546.0M | $1.1B | ||
| Q2 25 | $535.1M | $1.1B | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | $1.1B | ||
| Q3 24 | $822.7M | $1.1B | ||
| Q2 24 | $681.5M | $1.1B | ||
| Q1 24 | $680.4M | $992.8M |
| Q4 25 | $2.7B | $2.1B | ||
| Q3 25 | $2.8B | $2.1B | ||
| Q2 25 | $2.7B | $1.9B | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.5B | $1.8B | ||
| Q3 24 | $2.5B | $1.8B | ||
| Q2 24 | $2.4B | $1.7B | ||
| Q1 24 | $2.3B | $1.6B |
| Q4 25 | $5.3B | $4.9B | ||
| Q3 25 | $5.1B | $4.4B | ||
| Q2 25 | $4.9B | $4.2B | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.4B | $4.0B | ||
| Q3 24 | $4.6B | $4.1B | ||
| Q2 24 | $4.5B | $4.0B | ||
| Q1 24 | $4.4B | $3.8B |
| Q4 25 | 0.43× | 0.63× | ||
| Q3 25 | 0.20× | 0.51× | ||
| Q2 25 | 0.20× | 0.55× | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | 0.60× | ||
| Q3 24 | 0.32× | 0.59× | ||
| Q2 24 | 0.28× | 0.63× | ||
| Q1 24 | 0.29× | 0.61× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $81.5M |
| Free Cash FlowOCF − Capex | $96.9M | $70.3M |
| FCF MarginFCF / Revenue | 10.1% | 9.7% |
| Capex IntensityCapex / Revenue | 9.0% | 1.5% |
| Cash ConversionOCF / Net Profit | 2.47× | 1.49× |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $238.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $81.5M | ||
| Q3 25 | $177.6M | $46.6M | ||
| Q2 25 | $126.0M | $35.4M | ||
| Q1 25 | $82.7M | — | ||
| Q4 24 | $178.2M | $126.9M | ||
| Q3 24 | $229.3M | $101.0M | ||
| Q2 24 | $143.6M | $83.0M | ||
| Q1 24 | $92.3M | $44.5M |
| Q4 25 | $96.9M | $70.3M | ||
| Q3 25 | $114.3M | $37.4M | ||
| Q2 25 | $62.5M | $28.1M | ||
| Q1 25 | $25.9M | — | ||
| Q4 24 | $112.2M | $102.2M | ||
| Q3 24 | $162.7M | $90.4M | ||
| Q2 24 | $75.4M | $74.0M | ||
| Q1 24 | $16.7M | $37.1M |
| Q4 25 | 10.1% | 9.7% | ||
| Q3 25 | 11.9% | 5.2% | ||
| Q2 25 | 6.5% | 4.1% | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 13.2% | 15.2% | ||
| Q3 24 | 17.9% | 13.4% | ||
| Q2 24 | 8.3% | 10.5% | ||
| Q1 24 | 1.8% | 5.4% |
| Q4 25 | 9.0% | 1.5% | ||
| Q3 25 | 6.6% | 1.3% | ||
| Q2 25 | 6.6% | 1.1% | ||
| Q1 25 | 6.4% | — | ||
| Q4 24 | 7.8% | 3.7% | ||
| Q3 24 | 7.3% | 1.6% | ||
| Q2 24 | 7.5% | 1.3% | ||
| Q1 24 | 8.3% | 1.1% |
| Q4 25 | 2.47× | 1.49× | ||
| Q3 25 | 1.39× | 0.70× | ||
| Q2 25 | 1.13× | 0.53× | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | 2.36× | ||
| Q3 24 | 2.29× | 1.48× | ||
| Q2 24 | 1.59× | 1.00× | ||
| Q1 24 | 1.11× | 0.74× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
ESAB
| Consumable Products | $477.9M | 66% |
| Equipment Products | $249.9M | 34% |
